Does screening HIV-positive individuals in Uganda for major depressive disorder improve case detection rates and antidepressant prescription?

AIDS Behav. 2013 Oct;17(8):2802-7. doi: 10.1007/s10461-012-0383-y.

Abstract

Major depressive disorder in HIV-positive persons is often not diagnosed, and poorly treated. The effect of depression screening on case detection, and rates of antidepressant prescription is unknown.We assessed 368 participants for major depressive disorder, and provided clinicians with the results. Four weeks later, we abstracted information from the charts of the depressed patients to ascertain if they received antidepressants. We also randomly sampled the charts of 368 non-screened patients, to ascertain whether clinicians had diagnosed and prescribed antidepressant treatment.Major depressive disorder was identified in 17.9 % of the screened group, and in 2.1 % of the non-screened group [OR = 9.65, CI = (4.54-20.50)]. The screened individuals were 7.8 times more likely to receive antidepressants (95 % CI = 3.04-20.24). Identification of major depressive disorder by clinicians in HIV settings remains poor. However, routine screening can improve case detection rates and the proportion of patients receiving antidepressants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antidepressive Agents / therapeutic use*
  • Assessment of Medication Adherence*
  • Cross-Sectional Studies
  • Depressive Disorder, Major / diagnosis*
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / epidemiology
  • Disease Progression
  • Drug Prescriptions
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology*
  • HIV Infections / psychology
  • Humans
  • Male
  • Mass Screening*
  • Medication Adherence / psychology
  • Middle Aged
  • Practice Guidelines as Topic
  • Prevalence
  • Primary Health Care*
  • Uganda / epidemiology

Substances

  • Antidepressive Agents